These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3456985)

  • 21. The quinolone, flumequine, has no effect on theophylline pharmacokinetics.
    Lacarelle B; Blin O; Audebert C; Auquier P; Karsenty H; Horriere F; Durand A
    Eur J Clin Pharmacol; 1994; 46(5):477-8. PubMed ID: 7957547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pazufloxacin mesilate on the serum concentration of theophylline.
    Niki Y; Watanabe S; Yoshida K; Miyashita N; Nakajima M; Matsushima T
    J Infect Chemother; 2002 Mar; 8(1):33-6. PubMed ID: 11957117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent.
    Dagrosa EE; Verho M; Malerczyk V; de Looze S; Hajdú P; Toyodera K
    Clin Ther; 1986; 8(6):632-45. PubMed ID: 3466701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of ofloxacin from blood to sputum.
    Davies BI; Maesen FP; Geraedts WH; Baur C
    Drugs; 1987; 34 Suppl 1():26-32. PubMed ID: 3481324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.
    White LO; MacGowan AP; Lovering AM; Reeves DS; Mackay IG
    Drugs; 1987; 34 Suppl 1():56-61. PubMed ID: 3481329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.
    Kalager T; Digranes A; Bergan T; Rolstad T
    J Antimicrob Chemother; 1986 Jun; 17(6):795-800. PubMed ID: 3460984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of the cerebrospinal fluid penetrability of ofloxacin.
    Stübner G; Weinrich W; Brands U
    Infection; 1986; 14 Suppl 4():S250-3. PubMed ID: 3469155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot study.
    Wijnands WJ; Janssen TJ; Guelen PJ; Vree TB; De Witte TM
    Pharm Weekbl Sci; 1988 Dec; 10(6):272-6. PubMed ID: 3211700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No influence of doxycycline on theophylline pharmacokinetics.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
    Ther Drug Monit; 1985; 7(1):92-4. PubMed ID: 3992627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of influence of co-trimoxazole on theophylline pharmacokinetics.
    Jonkman JH; Van der Boon WJ; Schoenmaker R; Holtkamp AH; Hempenius J
    J Pharm Sci; 1985 Oct; 74(10):1103-4. PubMed ID: 3878403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic interaction between theophylline and a newly developed quinolone, NY-198.
    Kuzuya T; Takagi K; Apichartpichean R; Muraoka I; Nadai M; Hasegawa T
    J Pharmacobiodyn; 1989 Jul; 12(7):405-9. PubMed ID: 2593082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No effect of cefaclor on theophylline pharmacokinetics.
    Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Hempenius J
    Eur J Respir Dis; 1985 Jan; 66(1):47-9. PubMed ID: 3979475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence study of a fixed dose combination of nitazoxanide and ofloxacin in Indian healthy volunteers.
    Agarwal S; Solomon WD; Gowda KV; Selvan PS; Ghosh D; Sarkar AK; Chattaraj TK; Pal TK
    Arzneimittelforschung; 2007; 57(10):679-83. PubMed ID: 18074762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg].
    Veyssier P; Fourtillan JB; Modai J; Couet W; Lefebvre MA; Darchis JP; Vincent Du Laurier M; Bryskier A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):596-9. PubMed ID: 3534750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion of ofloxacin into human lung tissue.
    Couraud L; Fourtillan JB; Saux MC; Bryskier A; Vincent du Laurier M
    Drugs; 1987; 34 Suppl 1():37-8. PubMed ID: 3481326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decrease of caffeine elimination in man during co-administration of 4-quinolones.
    Stille W; Harder S; Mieke S; Beer C; Shah PM; Frech K; Staib AH
    J Antimicrob Chemother; 1987 Nov; 20(5):729-34. PubMed ID: 3480885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biliary tract excretion of ofloxacin in man.
    Kazmierczak A; Pechinot A; Duez JM; Haas O; Favre JP
    Drugs; 1987; 34 Suppl 1():39-43. PubMed ID: 3481327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.